Brookfield Renewable, Pepsi, and UPS are three high-yield stocks ideally suited for passive-income investors. The S&P 500 up ...

This was the stock's third consecutive day of gains.

What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts ...

Regeneron Pharmaceuticals (REGN) expands its focus on eye care with the acquisition of Oxular, a U.K.-based biotech ...

Fintel reports that on January 3, 2025, Raymond James downgraded their outlook for Vertex (NasdaqGM:VERX) from Outperform to ...

Vertex (VERX – Research Report) received a Hold rating and price target from Raymond James analyst Alexander Sklar today. The company’s ...

Foxtel sold for $3.4 billion to a British streaming outfit, while the ASX 200 gained 1.7 per cent, recouping much of last week's losses. Here's how the day's trade unfolded, with insights from our ...

Shares of Vertex Pharmaceuticals Inc. VRTX inched 0.84% higher to $402.70 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.43 ...

Fintel reports that on December 31, 2024, DA Davidson initiated coverage of Vertex (NasdaqGM:VERX) with a Buy recommendation.

DA Davidson analyst William Jellison initiated coverage on Vertex, Inc. VERX with a Buy rating and announced a price target ...

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

Stock futures rose Tuesday with tech back on top for the final day of 2024. Investor favorites such as MicroStrategy, Palantir and chip stocks led gains, after pulling back in recent days as traders ...